CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration

Annals of Internal Medicine

Volumn 167, Issue 2, 2017, Pages 112-121

  Cheng, Chung Wah ^b   Wu, Tai Xiang ^b   Shang, Hong Cai ^b   Li, You Ping ^b   Altman, Douglas G ^b   Moher, David ^b   Bian, Zhao Xiang ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METAL; WATER; HERBACEOUS AGENT;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CHINESE MEDICINE; CLINICAL PRACTICE; DRUG CONTAMINATION; DRUG FORMULATION; FIRE; HERB DRUG INTERACTION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; WESTERN MEDICINE; WOOD; CHECKLIST; HUMAN; METHODOLOGY; PUBLISHING; STANDARDS;

CHECKLIST; DRUGS, CHINESE HERBAL; HUMANS; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 85025086639     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M16-2977     Document Type: Article

References (38)

1. World Health Organization. WHO Traditional Medicine Strategy 2014-2023. December 2013. Accessed at http://apps.who.int/iris/bitstream/10665/92455/1/9789241506090-eng.pdf on 26 December 2016.
2. Chen KJ, Qian ZH, Zhang WQ, Guan WR, Wu XG, Chen XJ, et al. Effectiveness analysis for double-blinded treatment with refined coronary tablets on angina pectoris leaded by coronary heart disease in 112 cases [in Chinese]. Journal of Medical Sciences. 1982;11:24-5.
3. Wieland LS, Manheimer E, Sampson M, Barnabas JP, Bouter LM, Cho K, et al. Bibliometric and content analysis of the Cochrane Complementary Medicine Field specialized register of controlled trials. Syst Rev. 2013;2:51. [PMID: 23826877] doi:10.1186/2046-4053-2-51
4. Wang G, Mao B, Xiong ZY, Fan T, Chen XD, Wang L, et al; CONSORT Group for Traditional Chinese Medicine. The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China. Clin Ther. 2007;29:1456-67. [PMID: 17825697]
5. Wu T, Li Y, Bian Z, Liu G, Moher D. Randomized trials published in some Chinese journals: how many are randomized? Trials. 2009;10:46. [PMID: 19573242] doi:10.1186/1745-6215-10-46
6. He J, Du L, Liu G, Fu J, He X, Yu J, et al. Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews. Trials. 2011;12:122. [PMID: 21569452] doi:10.1186/1745-6215-12-122
7. Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev. 2012;1:60. [PMID: 23194585] doi:10.1186/2046-4053-1-60
8. Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C; CONSORT Group. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med. 2006;144:364-7. [PMID: 16520478]
9. MacPherson H, Altman DG, Hammerschlag R, Li Y, Wu T, White A, et al; STRICTA Revision Group. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Acupunct Med. 2010;28:83-93. [PMID: 20615861] doi:10.1136/aim.2009.001370
10. Liu Z, Liu L. Essentials of Chinese Medicine. vol 1. London: Springer-Verlag London; 2009.
11. World Health Organization Western Pacific Region. WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region. 2007. Accessed at www.wpro.who.int/publications/who-istrm-file.pdf on 11 February 2017.
12. Zhu WF. Differentiation of Pattern Elements [in Chinese]. 1st ed. Beijing: People's Medical Publishing House; 2008.
13. Bensky D, Barolet R. Chinese Herbal Medicine: Formulas & Strategies. Seattle: Eastland Pr; 1990.
14. Bensky D, Gamble A. Chinese Herbal Medicine: Materia Medica. Revised edition. Seattle: Eastland Pr, 1993.
15. Leung KS, Bian ZX, Moher D, Dagenais S, Li YP, Liu L, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part III: quality control of Chinese herbal medicine used in randomized controlled trials. Zhong Xi Yi Jie He Xue Bao. 2006;4:225-32. [PMID: 16696906]
16. Wu TX, Li YP, Bian ZX, Li TQ, Li J, Dagenais S, et al. Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM) [in Chinese]. Zhong Guo Xun Zheng Yi Xue Za Zhi. 2007;7:601-5.
17. Wu TX, Li YP, Bian ZX, Li TQ, Li J, Dagenais S, et al. Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM). Zhong Guo Xun Zheng Yi Xue Za Zhi. 2007;7: 625-30.
18. Dagenais S, Tricco AC, Bian ZX, Huang WH, Moher D. Critical appraisal of clinical studies in Chinese herbal medicine. Zhong Xi Yi Jie He Xue Bao. 2006;4:455-66. [PMID: 16965737]
19. Cheng CW, Bian ZX, Li YP, Moher D, Wu TX, Dagenais S, et al. CONSORT Serial 1: How to explain the methodological rationale of randomized, controlled trial on traditional Chinese medicine? [in Chinese]. Zhong Guo Xun Zheng Yi Xue Za Zhi. 2008;8:152-4.
20. Bian ZX, Moher D, Li YP, Wu TX, Dagenais S, Cheng CW, et al. Precise reporting of traditional Chinese medicine interventions in randomized controlled trials [Editorial]. Zhong Xi Yi Jie He Xue Bao. 2008;6:661-7. [PMID: 18601844] doi:10.3736/jcim20080701
21. Bian ZX, Moher D, Li YP, Wu TX, Dagenais S, Cheng CW, et al. Appropriately selecting and concisely reporting the outcome measures of randomized controlled trials of traditional Chinese medicine. Zhong Xi Yi Jie He Xue Bao. 2008;6:771-5. [PMID: 18664342] doi:10.3736/jcim20080801
22. Cheng CW, Bian ZX, Li YP, Moher D, Wu TX, Dagenais S, et al. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials [Editorial]. Zhong Xi Yi Jie He Xue Bao. 2008;6:881-6. [PMID: 18782527] doi:10.3736/jcim20080901
23. Bian Z, Liu B, Moher D, Wu T, Li Y, Shang H, et al. Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development. Front Med. 2011;5:171-7. [PMID: 21695622] doi:10.1007/s11684-011-0132-z
24. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726-32. [PMID: 20335313] doi:10.7326/0003-4819-152-11-201006010-00232
25. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014; 348: g1687. [PMID: 24609605] doi:10.1136/bmj.g1687
26. Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al; CONSORT Group. CONSORT for reporting randomised trials in journal and conference abstracts. Lancet. 2008;371:281-3. [PMID: 18221781] doi:10.1016/S0140-6736(07)61835-2
27. Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al; CONSORT Group. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med. 2008;5: e20. [PMID: 18215107] doi:10.1371/journal.pmed.0050020
28. Ioannidis JP, Evans SJ, Gøtzsche PC, O'Neill RT, Altman DG, Schulz K, et al; CONSORT Group. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 2004;141:781-8. [PMID: 15545678]
29. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340: c869. [PMID: 20332511] doi:10.1136/bmj.c869
30. Shen ZY. Reference criteria of deficiency syndrome diagnosis [in Chinese]. Zhong Guo Zhong Xi Yi Jie He Za Zhi. 1983;3:117.
31. First Conference of Blood Stasis of Society of Integrated Traditional and Western Medicine. Diagnosis criteria of blood stasis (tentative) [in Chinese]. Zhong Guo Zhong Xi Yi Jie He Za Zhi. 1983;3: cover page 2.
32. The State Administration of Traditional Chinese Medicine of the People's Republic of China. Criteria of Diagnosis and Therapeutic Effect of Diseases and Syndromes in Traditional Chinese Medicine [in Chinese]. Beijing: Nanjing Univ Pr; 1994.
33. Goodman SN, Fanelli D, Ioannidis JP. What does research reproducibility mean? Sci Transl Med. 2016;8:341ps12. [PMID: 27252173] doi:10.1126/scitranslmed.aaf5027
34. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China. Beijing: Chinese Medical Science Pr; 2010.
35. Watanabe K, Matsuura K, Gao P, Hottenbacher L, Tokunaga H, Nishimura K, et al. Traditional Japanese Kampo medicine: clinical research between modernity and traditional medicine-the state of research and methodological suggestions for the future. Evid Based Complement Alternat Med. 2011;2011:513842. [PMID: 21687585] doi:10.1093/ecam/neq067
36. Bian ZX, Moher D, Dagenais S, Li YP, Liu L, Wu TX, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part II: control group design. Zhong Xi Yi Jie He Xue Bao. 2006;4:130-6. [PMID: 16529687]
37. Berle CA, Cobbin D, Smith N, Zaslawski C. A novel approach to evaluate Traditional Chinese Medicine treatment outcomes using pattern identification. J Altern Complement Med. 2010;16:357-67. [PMID: 20374102] doi:10.1089/acm.2009.0367
38. Wang SQ, Gao Y, Wu SX. Thoughts on the clinical evaluation method of new medicine of syndrome TCM [in Chinese]. Shi Jie Zhong Yi Yao. 2014;9:1093-5.